Status:

RECRUITING

Ease of Use Study of the FemPulse System

Lead Sponsor:

FemPulse Corporation

Conditions:

Overactive Bladder (OAB)

Eligibility:

FEMALE

21+ years

Phase:

NA

Brief Summary

The objective of the study is to demonstrate that the FemPulse System can be used as indicated

Detailed Description

The objective of the study is to demonstrate that the FemPulse System can be used as indicated in the Patient and Clinician Instructions for Use (IFU), as applicable.

Eligibility Criteria

Inclusion

  • Key
  • Females, defined as a person with a cervix, ≥21 years old, with OAB symptoms, as confirmed by a physician. OAB is defined by urinary urgency, usually with urinary frequency and nocturia, with or without urgency urinary incontinence with symptoms .
  • Able to read, comprehend, and reliably provide informed consent and study-related information.
  • Willing and able to comply with study required procedures and visits

Exclusion

  • Any significant pain, neurologic, psychological condition or other factors, that in the investigator's judgment, might confound the protocol study assessments, and adherence to the protocol.
  • Has a metal pelvic implant or an active implantable medical device, including but not limited to a cardiac pacemaker, cardioverter-defibrillator or neurostimulator 3 History of a cardiac condition including, but not limited to, clinically significant abnormal ECG or arrhythmia that may interfere with study participation as determined by investigator.
  • 4\. Systemic condition or disease that may interfere with study participation or not an appropriate study candidate, as determined by study investigator.

Key Trial Info

Start Date :

February 11 2025

Trial Type :

INTERVENTIONAL

Allocation :

ESTIMATED

End Date :

August 31 2025

Estimated Enrollment :

20 Patients enrolled

Trial Details

Trial ID

NCT06885099

Start Date

February 11 2025

End Date

August 31 2025

Last Update

March 20 2025

Active Locations (1)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (1 locations)

1

Holy Cross Women's Hospital

Fort Lauderdale, Florida, United States, 33334